A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease-Reference-Cited by-同舟云学术

A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease

Published:2015-02 Issue:2 Volume:63 Page:479-488
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Kulik Liudmila,Hewitt Finnegan B.,Willis Van C.,Rodriguez Rosa,Tomlinson Stephen,Michael Holers V.

Funder

NIH

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference67 articles.

1. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21);Ahearn;Adv. Immunol.,1989

2. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection;Atkinson;J. Clin. Invest.,2005

3. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors;Baiu;J. Immunol.,1999

4. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein;Boackle;Immunity,2001

5. The CD19 signal transduction complex of B lymphocytes;Bradbury;J. Immunol.,1993

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Foot-and-mouth disease virus localisation on follicular dendritic cells and sustained induction of neutralising antibodies is dependent on binding to complement receptors (CR2/CR1);PLOS Pathogens;2022-05-05

2. Foot-and-mouth disease virus localisation on follicular dendritic cells and sustained induction of neutralising antibodies is dependent on binding to complement receptors (CR2/CR1);2021-09-08

3. Complement Properdin Determines Disease Activity in MRL/lpr Mice;Medicina;2020-08-27

4. Targeting the Immune Complex–Bound Complement C3d Ligand as a Novel Therapy for Lupus;The Journal of Immunology;2019-11-15

5. The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models;Molecular Immunology;2019-01